In search of the neuroprotective mechanism of thiazolidinediones in Parkinson's disease

被引：16

作者：

Ridder, Dirk A. ^{[1
]}

Schwaninger, Markus ^{[1
]}

机构：

[1] Univ Lubeck, Inst Expt & Clin Pharmacol & Toxicol, D-23538 Lubeck, Germany

来源：

EXPERIMENTAL NEUROLOGY | 2012年 / 238卷 / 02期

关键词：

MPTP; MPP+; Glitazones; Oxidative stress; PPAR gamma; ACTIVATED-RECEPTOR-GAMMA; NF-KAPPA-B; CENTRAL-NERVOUS-SYSTEM; PROGRAMMED CELL-DEATH; PPAR-GAMMA; MOUSE MODEL; AGONIST PIOGLITAZONE; ALZHEIMERS-DISEASE; MITOCHONDRIAL DYSFUNCTION; INFLAMMATORY RESPONSE;

D O I：

10.1016/j.expneurol.2012.08.012

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

The oral antidiabetic thiazolidinediones exert protective effects in models of Parkinson's disease and other neurological diseases. While the antidiabetic effect is due to activation of PPAR gamma, the mechanisms underlying the neuroprotection are more controversial. It may involve activation of PPAR gamma blocking inflammation and apoptosis. However, new evidence suggests an antioxidative PPAR gamma-independent action. Here we discuss recent data on the mode of action of TZDs in models of PD and their implication for the translation into the clinic. (C) 2012 Elsevier Inc. All rights reserved.

引用

页码：133 / 137

页数：5

共 61 条

[41] Individual dopaminergic neurons show raised iron levels in Parkinson disease
Oakley, A. E.
Collingwood, J. F.
Dobson, J.
Love, G.
Perrott, H. R.
Edwardson, J. A.
Elstner, M.
Morris, C. M.
[J]. NEUROLOGY, 2007, 68 (21) : 1820 - 1825
[42] A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
Pascual, G
Fong, AL
Ogawa, S
Gamliel, A
Li, AC
Perissi, V
Rose, DW
Willson, TM
Rosenfeld, MG
Glass, CK
[J]. NATURE, 2005, 437 (7059) : 759 - 763
[43] The PPARγ agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B
Quinn, L. P.
Crook, B.
Hows, M. E.
Vidgeon-Hart, M.
Chapman, H.
Upton, N.
Medhurst, A. D.
Virley, D. J.
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (01) : 226 - 233
[44] NF-κB SIGNALING IN CEREBRAL ISCHEMIA
Ridder, D. A.
Schwaninger, M.
[J]. NEUROSCIENCE, 2009, 158 (03) : 995 - 1006
[45] Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARγ target gene involved in neuroprotection
Romera, Cristina
Hurtado, Olivia
Mallolas, Judith
Pereira, Marta P.
Morales, Jesus R.
Romera, Alejandro
Serena, Joaquin
Vivancos, Jose
Nombela, Florentino
Lorenzo, Pedro
Lizasoain, Ignacio
Moro, Maria A.
[J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2007, 27 (07) : 1327 - 1338
[46] A role for central nervous system PPAR-γ in the regulation of energy balance
Ryan, Karen K.
Li, Bailing
Grayson, Bernadette E.
Matter, Emily K.
Woods, Stephen C.
Seeley, Randy J.
[J]. NATURE MEDICINE, 2011, 17 (05) : 623 - U145
[47] PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease
Schintu, Nicoletta
Frau, Lucia
Ibba, Marcello
Caboni, Pierluigi
Garau, Arianna
Carboni, Ezio
Carta, Anna R.
[J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2009, 29 (05) : 954 - 963
[48] The Action and Mode of Binding of Thiazolidinedione Ligands at Free Fatty Acid Receptor 1
Smith, Nicola J.
Stoddart, Leigh A.
Devine, Nicola M.
Jenkins, Laura
Milligan, Graeme
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (26) : 17527 - 17539
[49] Synthesis of Lipoxin A4 by 5-Lipoxygenase Mediates PPARγ-Dependent, Neuroprotective Effects of Rosiglitazone in Experimental Stroke
Sobrado, Monica
Pereira, Marta P.
Ballesteros, Ivan
Hurtado, Olivia
Fernandez-Lopez, David
Pradillo, Jesus M.
Caso, Javier R.
Vivancos, Jose
Nombela, Florentino
Serena, Joaquin
Lizasoain, Ignacio
Moro, Maria A.
[J]. JOURNAL OF NEUROSCIENCE, 2009, 29 (12) : 3875 - 3884
[50] The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse
Steneberg, R
Rubins, N
Bartoov-Shifman, R
Walker, MD
Edlund, H
[J]. CELL METABOLISM, 2005, 1 (04) : 245 - 258

← 1 2 3 4 5 6 7 →